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Perspectives

The Million Death Study in India: Can It
Help in Monitoring the Millennium
Development Goals?
Zulﬁqar A. Bhutta

T

he Registrar General of
India’s Sample Registration
System (SRS), a large routine
demographic survey, is the country’s
primary system for the collection of
fertility and mortality data (Box 1). It
is widely regarded as an innovative way
of capturing essential information on
mortality patterns that may inﬂuence
public health policy. However,
although this monitoring system has
been in place since 1971, there are
relatively few evaluations to indicate
if the SRS is truly representative or
functional as a robust monitoring
system.
The Million Death Study in India is
an ambitious project being undertaken
by the SRS in close collaboration with
the Centre for Global Health Research
at the University of Toronto, leading
Indian and other overseas academic
institutions, and the Indian Council
of Medical Research. The study will
use the SRS framework to obtain
information, from a reasonably large
cohort of deaths (1 million deaths
over 16 years), on the underlying
causes of child and adult deaths, as
well as key risk factors for these deaths
(behavioral, physical, environmental,
and, possibly, genetic). In a new study
in PLoS Medicine, Prabhat Jha and
colleagues report on the rationale,
design, and implementation of the
Million Death Study in India [1].
The study will use a combination
of methods, looking at both a
retrospective and a prospective cohort
of deaths. These methods include case
control studies, risk assessments, and
genetic association studies. Given the
unique characteristics of the healthcare system in India, and the country’s
enormous double burden of infectious
and noncommunicable diseases,
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Box 1. Sample Frames of India’s
SRS
“There are two SRS sample frames. The
ﬁrst SRS sample frame covers 6.3 million
people (including 2.9 million adults
aged 25 years or older) in all 28 states
and seven union territories of India. An
average of 150 households are drawn
from each of 6,671 sample units (4,436
rural and 2,235 urban), which in turn are
selected using 1991 census data. The
new SRS sample frame covers about
7.6 million people (including 3.5 million
adults aged 25 years or older) in all 28
states and seven union territories of India.
Households are drawn from 7,597 sample
units (4,433 rural and 3,164 urban)
selected from the 2001 census” [1].

the Million Death Study will provide
valuable information for India that may
also be relevant to other developing
countries.
The researchers involved in the
study have shown great foresight in
making their protocols available for
public scrutiny. It may, therefore,
be worthwhile to ask a few pertinent
questions at this early stage in the
project.

Is the “Large Sample” Truly
Representative?
Is the SRS framework adequate for
India’s current and future surveillance
needs? While the scale of the study
and the sample of 1 million deaths
spanning the period 1998–2014 is
daunting, one can see some limitations
of this unique exercise given the
population size and diversity in India.
The study is largely embedded within
the revised SRS framework, and
capitalizes on the existing system.
Although the new SRS sample frame is
larger than before, the 7,597 sampling
units cover only 7.6 million people
out of India’s population of just over 1
billion people. The new sample covers
0163

only half a million of an estimated
annual 9.5 million deaths in India.
Public health surveillance and
monitoring systems have a key role in
local health policymaking, so it would
have been valuable for the SRS to have
given information with district-level
speciﬁcity. It is also unclear if the SRS
sample covers pockets of deprivation
in urban and periurban slums, where
health care and health indicators are
even worse than in rural populations
[2]. Given the increasingly devolved
health-care system, any surveillance
and monitoring system must have local
speciﬁcity, and given the scope and
timescale of the study, these issues
are best addressed at the outset. This
study could have been the stimulus to
expand the SRS sample size to reﬂect
district level trends, as well as maternal
mortality (a reduction in maternal
mortality is an important Millennium
Development Goal [MDG]).
The major limitation in terms of
expanding the SRS is cost. The current
study is being undertaken with an
incremental budget of a mere US$2
million. While the resources are clearly
a limitation for this study, the low
level of public health spending in the
region nevertheless largely reﬂects
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misplaced priorities [3]. I would argue
that perhaps the study itself might have
been the impetus to expand the SRS
sample to a more representative sample
with the power to track important MDG
indicators in all strata.

Is the Focus Appropriate?
The Million Death Study largely
focuses on adult mortality and, as
indicated by the authors, it may not
have sufﬁcient power to address
maternal mortality. This is unfortunate
because the persistently high burden
of maternal morbidity and mortality is
a unique challenge for South Asia [4].
While the constraints of an adequate
population sample for maternal
mortality are understandable, it would
have been useful to see a few more
reproductive health indicators in the
current repertoire of risk factors that
the investigators intend to track. With
the global health community now
focusing on achieving the MDGs [5],
it is important to critically review and
expand the repertoire of studies on
maternal and childhood mortality.
India has a high burden of fetal
malnutrition [6], so it is also important
to strengthen the emerging evidence
of the link between maternal and fetal
malnutrition, childhood growth, and
long-term adverse outcomes such as
diabetes and premature cardiovascular
disease [7–8]. It may be possible to
include variables on size at birth and
early growth parameters within the
planned substudies of the Million
Death Study, as these variables may
be important correlates of adult-onset
diseases and premature mortality.

Are the Tools Robust?
Although the validity of routinely
monitoring health data by healthsystem employees can be questioned,
the proposed study will have additional
components that will involve secondary
analyses of the data by external
staff. It would also be important to
have protocols in place for regular
external validation of the primary
data. Previous evaluations have shown
close concordance between the data
on smoking and alcohol consumption
generated by the Special Fertility and
Mortality Survey (the baseline survey of
the Million Death Study) [9] and the
data from the National Family Health
Survey 2 (the National Family Health
Survey is a large-scale, multiround
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survey coordinated by India’s
International Institute for Population
Sciences) [10], suggesting that the SRS
data are indeed robust. Nevertheless,
such cross-checking of the primary
SRS data would be necessary through
additional periodic surveys.
The Million Death Study proposes
to use verbal autopsy instruments, for
example, recording details of deaths
as reported by family or friends to a
trained but nonmedical ﬁeldworker.
Verbal autopsy instruments are already
in use for recording SRS deaths, and
they have been validated for adult
mortality, except for those at the

The challenge
is to ensure that
the study is relevant
to the MDG targets
that India has set itself.
extremes of age. The infant and child
verbal autopsy tool [11] referred to
in the proposed study has not been
validated for use within the neonatal
period, and several modiﬁcations
have been made to adapt it to such
use [12–14]. Given that almost 50% of
all infant deaths in India occur in the
neonatal period [15], the validation
of the verbal autopsy tool employed in
the SRS is critically important. Such
studies for validation of modiﬁed
neonatal verbal autopsy instruments
are currently underway (S. Qazi,
World Health Organization, personal
communication).
While the current study plans
to focus on the “usual suspects” in
causing neonatal deaths, such as deaths
due to birth asphyxia, prematurity,
and serious infections, it is equally
important to be aware of emerging
issues in neonatal health. The high
global burden of stillbirths, especially
those that occur in the intrapartum
period, has been recently recognized
[16]. Given that these deaths may
represent the hidden burden of
birth asphyxia and perinatal care,
it would be appropriate to evaluate
the importance of fresh stillbirths in
the current framework (the Million
Death Study framework appears to
exclude stillbirths). The same may
apply to infant deaths relating to
malformations such as neural tube
defects [17], which may represent both
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widespread nutritional deﬁciencies and
genetic polymorphisms. The planned
study offers a unique opportunity to
capture the true burden of premature
mortality and potentially decrease
handicaps relating to perinatal events
and congenital malformations, on
which almost no data exist from large
population settings.

Ethical Considerations
The planned inclusion of genetic
studies and the setting up of biobanks (collections of samples of
bodily substances that are, or can be,
associated with personal data) are a
welcome initiative, as these studies
have important implications for public
health preventive strategies [18].
However, the use of such tools and
research must be strictly regulated
by ethical guidelines and criteria,
such as those developed by the
Indian Council for Medical Research
[19]. The ethical issues involved in
the use of biological materials in
population surveys are a subject of
intense debate, and while there are
few universally applicable guidelines
[20], the Million Death Study offers
an opportunity for progress in this
dynamic ﬁeld. Although these ethical
aspects are not fully elaborated in
the current proposal, one hopes that
the investigators will use the available
opportunity to address them. While
these ethical issues may be important in
mortality studies, they are particularly
germane to the planned nested casecontrol studies.

Conclusion
In summary, despite the questions I
have raised above, the Million Death
Study is one of the most important
projects in population health, with the
real potential of addressing priority
issues in public health. The challenge
is to ensure that the study is relevant
to the MDG targets that India has
set itself, and that it also informs
public health policy as it evolves.
Addressing this challenge may mean
potentially increasing the sampling
frame to make the data more relevant
at the district level, and including
additional maternal and newborn
health indicators within the current
repertoire. Pushing the envelope in an
already large project at this stage may
yield much greater dividends in due
course. 
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